157 related articles for article (PubMed ID: 25741627)
21. Mass-weighted molecular dynamics simulation of cyclic polypeptides.
Mao B; Maggiora GM; Chou KC
Biopolymers; 1991 Aug; 31(9):1077-86. PubMed ID: 1786339
[TBL] [Abstract][Full Text] [Related]
22. A critical assessment of force field accuracy against NMR data for cyclic peptides containing β-amino acids.
Paissoni C; Nardelli F; Zanella S; Curnis F; Belvisi L; Musco G; Ghitti M
Phys Chem Chem Phys; 2018 Jun; 20(23):15807-15816. PubMed ID: 29845162
[TBL] [Abstract][Full Text] [Related]
23. N-methylated cyclic pentaalanine peptides as template structures.
Chatterjee J; Mierke D; Kessler H
J Am Chem Soc; 2006 Nov; 128(47):15164-72. PubMed ID: 17117868
[TBL] [Abstract][Full Text] [Related]
24. Relaxation time prediction for a light switchable peptide by molecular dynamics.
Denschlag R; Schreier WJ; Rieff B; Schrader TE; Koller FO; Moroder L; Zinth W; Tavan P
Phys Chem Chem Phys; 2010 Jun; 12(23):6204-18. PubMed ID: 20390205
[TBL] [Abstract][Full Text] [Related]
25. Toward structure prediction of cyclic peptides.
Yu H; Lin YS
Phys Chem Chem Phys; 2015 Feb; 17(6):4210-9. PubMed ID: 25566700
[TBL] [Abstract][Full Text] [Related]
26. Cyclic Peptide Design Guided by Residual Dipolar Couplings, J-Couplings, and Intramolecular Hydrogen Bond Analysis.
Farley KA; Che Y; Navarro-Vázquez A; Limberakis C; Anderson D; Yan J; Shapiro M; Shanmugasundaram V; Gil RR
J Org Chem; 2019 Apr; 84(8):4803-4813. PubMed ID: 30605335
[TBL] [Abstract][Full Text] [Related]
27. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
28. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
Manzoni L; Belvisi L; Arosio D; Civera M; Pilkington-Miksa M; Potenza D; Caprini A; Araldi EM; Monferini E; Mancino M; Podestà F; Scolastico C
ChemMedChem; 2009 Apr; 4(4):615-32. PubMed ID: 19212960
[TBL] [Abstract][Full Text] [Related]
29. Accurate Structure Prediction and Conformational Analysis of Cyclic Peptides with Residue-Specific Force Fields.
Geng H; Jiang F; Wu YD
J Phys Chem Lett; 2016 May; 7(10):1805-10. PubMed ID: 27128113
[TBL] [Abstract][Full Text] [Related]
30. Solvent-Enhanced Conformational Flexibility of Cyclic Tetrapeptides.
Berger N; Wollny LJB; Sokkar P; Mittal S; Mieres-Perez J; Stoll R; Sander W; Sanchez-Garcia E
Chemphyschem; 2019 Jul; 20(13):1664-1670. PubMed ID: 31045298
[TBL] [Abstract][Full Text] [Related]
31. Conformation and dynamics of a cyclic disulfide-bridged peptide: effects of temperature and solvent.
Li F; Bravo-Rodriguez K; Phillips C; Seidel RW; Wieberneit F; Stoll R; Doltsinis NL; Sanchez-Garcia E; Sander W
J Phys Chem B; 2013 Apr; 117(13):3560-70. PubMed ID: 23514118
[TBL] [Abstract][Full Text] [Related]
32. Conformational interconversion in compstatin probed with molecular dynamics simulations.
Mallik B; Lambris JD; Morikis D
Proteins; 2003 Oct; 53(1):130-41. PubMed ID: 12945056
[TBL] [Abstract][Full Text] [Related]
33. Constraining cyclic peptides to mimic protein structure motifs.
Hill TA; Shepherd NE; Diness F; Fairlie DP
Angew Chem Int Ed Engl; 2014 Nov; 53(48):13020-41. PubMed ID: 25287434
[TBL] [Abstract][Full Text] [Related]
34. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
35. Increasing αvβ3 selectivity of the anti-angiogenic drug cilengitide by N-methylation.
Mas-Moruno C; Beck JG; Doedens L; Frank AO; Marinelli L; Cosconati S; Novellino E; Kessler H
Angew Chem Int Ed Engl; 2011 Sep; 50(40):9496-500. PubMed ID: 21948451
[No Abstract] [Full Text] [Related]
36. Molecular dynamics study of a carbon nanotube binding reversible cyclic peptide.
Chiu CC; Maher MC; Dieckmann GR; Nielsen SO
ACS Nano; 2010 May; 4(5):2539-46. PubMed ID: 20423073
[TBL] [Abstract][Full Text] [Related]
37. Multiple N-methylation by a designed approach enhances receptor selectivity.
Chatterjee J; Ovadia O; Zahn G; Marinelli L; Hoffman A; Gilon C; Kessler H
J Med Chem; 2007 Nov; 50(24):5878-81. PubMed ID: 17973471
[TBL] [Abstract][Full Text] [Related]
38. A molecular dynamics simulation investigation of the relative stability of the cyclic peptide octreotide and its deprotonated and its (CF
Smith LJ; Rought Whitta G; Dolenc J; Wang D; van Gunsteren WF
Bioorg Med Chem; 2016 Oct; 24(20):4936-4948. PubMed ID: 27543388
[TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics investigation of cyclic natriuretic peptides: dynamic properties reflect peptide activity.
Papaleo E; Russo L; Shaikh N; Cipolla L; Fantucci P; De Gioia L
J Mol Graph Model; 2010 Jun; 28(8):834-41. PubMed ID: 20347361
[TBL] [Abstract][Full Text] [Related]
40. Cofactor-free detection of phosphatidylserine with cyclic peptides mimicking lactadherin.
Zheng H; Wang F; Wang Q; Gao J
J Am Chem Soc; 2011 Oct; 133(39):15280-3. PubMed ID: 21899316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
